Related Experiment Video
Updated: Jan 11, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Neurodevelopmental features in KCNQ2 developmental and epileptic encephalopathy may have limited associations with
Jessa S Bidwell1, Carlos G Vanoye2, Reshma R Desai2
1Graduate Program in Genetic Counseling, Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Genetic variants in KCNQ2 cause developmental and epileptic encephalopathy (DEE). Severe loss of function variants correlate with worse neurodevelopmental outcomes in KCNQ2-DEE patients.
Area of Science:
- Genetics
- Neuroscience
- Molecular Biology
Background:
- KCNQ2 gene variants are linked to developmental and epileptic encephalopathy (DEE).
- The severity of DEE varies significantly among affected individuals.
- Understanding the genotype-phenotype correlation is crucial for predicting disease trajectory.
Purpose of the Study:
- To investigate the relationship between KCNQ2 variant dysfunction and the neurodevelopmental phenotype in KCNQ2-DEE.
- To analyze the impact of different variant functional classifications on clinical severity.
- To identify factors contributing to the variability in KCNQ2-DEE.
Main Methods:
- A parent-reported survey collected clinical and genetic data from individuals with KCNQ2-DEE.
- A composite non-seizure phenotype severity score (PSS) was developed for six key features.
- KCNQ2 variant function was assessed using voltage-clamp recordings and classified as severe loss of function (SLOF), loss of function (LOF), wild-type-like (WTL), or gain of function (GOF).
Main Results:
- 48 individuals with 38 unique KCNQ2 variants were included.
- The phenotype severity score (PSS) was higher in individuals with SLOF variants compared to LOF variants (p=0.02).
- A lower prevalence of epileptic spasms was observed in individuals with dominant-negative variants among those with SLOF or LOF variants.
Conclusions:
- Multiple and severe neurodevelopmental impairments are common in KCNQ2-DEE.
- KCNQ2 channel dysfunction shows a modest correlation with overall non-seizure phenotype severity.
- Factors beyond channel dysfunction likely contribute to the variable clinical severity observed in KCNQ2-DEE.
More Related Videos
11:54Simultaneous Video-EEG-ECG Monitoring to Identify Neurocardiac Dysfunction in Mouse Models of Epilepsy
Published on: January 29, 2018
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Overview of Synapses